Cutaneous toxicities are the most prevalent immune-related adverse events. Various reactions have been reported. In this review, we summarized the clinicopathologic manifestations, treatment strategies, relevance to tumor outcomes, and rechallenge considerations of cutaneous immune-related adverse events.
Keywords: cutaneous toxicities; immune checkpoint inhibitors; immune-related adverse events; outcomes; rechallenge.
© 2020 John Wiley & Sons Australia, Ltd.